{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:02:19Z","timestamp":1794358939646,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1208\/s12249-020-01699-9","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T16:03:53Z","timestamp":1591373033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment"],"prefix":"10.1208","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-0278","authenticated-orcid":false,"family":"Ameeduzzafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil K","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Sarim","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser Hadal","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil A.","family":"Alhakamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Saad","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattam Khulaif","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Nasir Abbas","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"1699_CR1","doi-asserted-by":"crossref","unstructured":"Zafar A, Ahmad J, Addo RT, Akhter S. Progress of controlled drug delivery systems in topical ophthalmology: focus on nano and micro drug carriers. In: Addo R, editor Ocular drug delivery: advances, challenges and applications. Springer; 2016. p. 131\u2013163.","DOI":"10.1007\/978-3-319-47691-9_9"},{"key":"1699_CR2","doi-asserted-by":"crossref","unstructured":"Zafar A, Ahmad J, Akhter S, Addo RT. Nanotechnology for transcorneal drug targeting in glaucoma: challenges and progress. In: Addo R, editor. Ocular drug delivery: advances, challenges and applications. Springer; 2016. p. 75\u201399.","DOI":"10.1007\/978-3-319-47691-9_6"},{"key":"1699_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2017.07.035","volume":"268","author":"L Lalu","year":"2017","unstructured":"Lalu L, Tambe V, Pradhan D, Nayak K, Bagchi S, Maheshwari R, et al. Novel nanosystems for the treatment of ocular inflammation: current paradigms and future research directions. J Control Release. 2017;268:19\u201339.","journal-title":"J Control Release"},{"key":"1699_CR4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/0976-9668.166051","volume":"6","author":"AK Hazarika","year":"2015","unstructured":"Hazarika AK, Singh PK. Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis. J Nat Sci Biol Med. 2015;6:510\u20132.","journal-title":"J Nat Sci Biol Med"},{"key":"1699_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/md16100373","volume":"16","author":"T Irimia","year":"2018","unstructured":"Irimia T, Dinu-Pirvu CE, Ghica MV, Lupuleasa D, Muntean DL, Udeanu DI, et al. Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review. Mar Drugs. 2018;16:373.","journal-title":"Mar Drugs"},{"key":"1699_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10837450903479988","volume":"16","author":"G Abdelbary","year":"2011","unstructured":"Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol. 2011;16:44\u201356.","journal-title":"Pharm Dev Technol"},{"key":"1699_CR7","first-page":"1921","volume":"8","author":"Y Dai","year":"2013","unstructured":"Dai Y, Zhou RL, Lu Y, Qi J, Wu W. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine. 2013;8:1921\u201333.","journal-title":"Int J Nanomedicine"},{"key":"1699_CR8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","volume":"9","author":"G Abdelbary","year":"2008","unstructured":"Abdelbary G, El-gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech. 2008;9:740\u20137.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"2","key":"1699_CR9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/08982104.2016.1167737","volume":"27","author":"RM Khalil","year":"2008","unstructured":"Khalil RM, Abdelbary GA, Basha M, Awad GE, El-Hashemy HA. Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. J Liposome Res. 2008;27(2):118\u201329.","journal-title":"J Liposome Res"},{"key":"1699_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","volume":"396","author":"L Gan","year":"2010","unstructured":"Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm. 2010;396:179\u201387.","journal-title":"Int J Pharm"},{"key":"1699_CR11","first-page":"683","volume":"6","author":"J Hao","year":"2011","unstructured":"Hao J, Fang X, Zhou Y, Wang J, Guo F, Li-Peng FX. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine. 2011;6:683\u201392.","journal-title":"Int J Nanomedicine"},{"key":"1699_CR12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.colsurfb.2018.08.046","volume":"172","author":"F Zhao","year":"2018","unstructured":"Zhao F, Lu J, Jin X, Wang Z, Sun Y, Gao D, et al. Comparison of response surface methodology and artificial neural network to optimize novel ophthalmic flexible nano-liposomes: characterization, evaluation, in vivo pharmacokinetics and molecular dynamics simulation. Colloids Surf B: Biointerfaces. 2018;172:288\u201397.","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"Pt B","key":"1699_CR13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejpb.2015.02.019","volume":"95","author":"S Reimondez-Troiti\u00f1o","year":"2015","unstructured":"Reimondez-Troiti\u00f1o S, Csaba N, Alonso MJ, de la Fuente M. Nanotherapies for the treatment of ocular diseases. Eur J Pharm Biopharm. 2015;95(Pt B):279\u201393.","journal-title":"Eur J Pharm Biopharm"},{"key":"1699_CR14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/pharmaceutics11090460","volume":"11","author":"EB Souto","year":"2019","unstructured":"Souto EB, Dias-Ferreira J, L\u00f3pez-Machado A, Ettcheto M, Cano A, Camins Espuny A, et al. Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents. Pharmaceutics. 2019;11:460.","journal-title":"Pharmaceutics."},{"key":"1699_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-409X(00)00123-X","volume":"47","author":"KA Janes","year":"2001","unstructured":"Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47:83\u201397.","journal-title":"Adv Drug Deliv Rev"},{"key":"1699_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2016.03.061","volume":"143","author":"H Chen","year":"2016","unstructured":"Chen H, Pan H, Li P, Wang H, Wang X, Pan W, et al. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system. Colloids Surf B: Biointerfaces. 2016;143:455\u201362.","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"1699_CR17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.curtheres.2014.11.001","volume":"77","author":"MM Masadeh","year":"2015","unstructured":"Masadeh MM, Alzoubi KH, Khabour OF, Al-Azzam SI. Ciprofloxacin-induced antibacterial activity is attenuated by phosphodiesterase inhibitors. Curr Ther Res Clin Exp. 2015;77:14\u20137.","journal-title":"Curr Ther Res Clin Exp"},{"key":"1699_CR18","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.2147\/DDDT.S116443","volume":"10","author":"K Karimi","year":"2016","unstructured":"Karimi K, Pallagi E, Szabo-Revesz P, Csoka I, Ambrus R. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach. Drug Design Dev Ther. 2016;10:3331\u201343.","journal-title":"Drug Design Dev Ther"},{"key":"1699_CR19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/nano8050304","volume":"8","author":"R Pignatello","year":"2018","unstructured":"Pignatello R, Leonardi A, Fuochi V, Petronio G, Antonio S, Pio M, et al. Method for efficient loading of ciprofloxacin hydrochloride in cationic solid lipid nanoparticles: formulation and microbiological evaluation. Nanomaterials. 2018;8:304.","journal-title":"Nanomaterials."},{"issue":"1","key":"1699_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-009-9373-4","volume":"11","author":"KM Hosny","year":"2010","unstructured":"Hosny KM. Ciprofloxacin as ocular liposomal hydrogel. AAPS Pharm Sci Tech. 2010;11(1):241\u20136.","journal-title":"AAPS Pharm Sci Tech"},{"key":"1699_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/01932690701688482","volume":"29","author":"MA Kalam","year":"2008","unstructured":"Kalam MA, Sultana A, Samad A, Ali A, Aqil M, Sharma M, et al. Gelrite based in vitro gelation ophthalmic drug delivery system of ciprofloxacin. J Dispers Sci Technol. 2008;29:89\u201396.","journal-title":"J Dispers Sci Technol"},{"issue":"8","key":"1699_CR22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/10717544.2013.870260","volume":"22","author":"SS Imam","year":"2015","unstructured":"Imam SS, Aqil M, Akhtar M, Sultana Y, Ali A. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Delivery. 2015;22(8):1059\u201370.","journal-title":"Drug Delivery"},{"key":"1699_CR23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijbiomac.2014.02.002","volume":"65","author":"AJ Ameeduzzafar","year":"2014","unstructured":"Ameeduzzafar AJ, Bhatnagar A, Kumar N, Ali A. Chitosan nanoparticles amplify the ocular hypotensive effect of carteolol in rabbits. Int J Biol Macromol. 2014;65:479\u201391.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"1699_CR24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/10717544.2019.1609622","volume":"26","author":"A Emad Eldeeb","year":"2019","unstructured":"Emad Eldeeb A, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019;26(1):509\u201321.","journal-title":"Drug Deliv"},{"key":"1699_CR25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijbiomac.2017.11.170","volume":"108","author":"Ameeduzzafar","year":"2018","unstructured":"Ameeduzzafar, Imam SS, Bukhari SNA, Ahmad J, Ali A. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: in-vitro characterization, ocular tolerance and antibacterial activity. Int J Biol Macromol. 2018;108:650\u20139.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"1699_CR26","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.3390\/pharmaceutics10020038","volume":"10","author":"F Rinaldi","year":"2018","unstructured":"Rinaldi F, Hanieh PN, Chan LKN, Angeloni L, Passeri D, Rossi M, et al. Chitosan glutamate-coated niosomes: a proposal for nose-to-brain delivery. Pharmaceutics. 2018;10(2):E38.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1699_CR27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1166\/sam.2014.1681","volume":"6","author":"Ameeduzzafar","year":"2014","unstructured":"Ameeduzzafar, Ali J, Nazia K, Ali A. Development and optimization of carteolol loaded carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic delivery: Box-Behnken design, in vitro, ex vivo assessment. Sci Adv Mater. 2014;6(1):63\u201375.","journal-title":"Sci Adv Mater"},{"issue":"5","key":"1699_CR28","volume":"33","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Wang Z, Lui G, Hirt D, Treluyer JM, Benaboud S, et al. Simultaneous quantification of levofloxacin, pefloxacin, ciprofloxacin and moxifloxacin in microvolumes of human plasma using high performance liquid chromatography with ultraviolet detection. Biomed Chromatogr. 2019;33(5):e4506.","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"1699_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0378-5173(02)00557-4","volume":"250","author":"D Monti","year":"2003","unstructured":"Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone MF. Effect of iontophoresis on transcorneal permeation 'in vitro' of two beta-blocking agents, and on corneal hydration. Int J Pharm. 2003;250(2):423\u20139.","journal-title":"Int J Pharm"},{"key":"1699_CR30","unstructured":"Frame E. Data Bank of in vitro techniques in toxicology: hen\u2019s egg test, INVITOX protocol 15 Ergatt\/Frame (1990)."},{"issue":"1","key":"1699_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.carbpol.2007.11.007","volume":"73","author":"S Papadimitriou","year":"2008","unstructured":"Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym. 2008;73(1):44\u201354.","journal-title":"Carbohydr Polym"},{"key":"1699_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0973-8398.76752","volume":"4","author":"E Essa","year":"2010","unstructured":"Essa E. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 2010;4:227.","journal-title":"Asian J Pharm"},{"issue":"1","key":"1699_CR33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/10717544.2018.1477861","volume":"25","author":"NH Fouda","year":"2018","unstructured":"Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. Sustained ocular delivery of dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2018;25(1):1340\u20139.","journal-title":"Drug Deliv"},{"issue":"4","key":"1699_CR34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1248\/bpb.b13-00724","volume":"37","author":"II Abu Hashim","year":"2014","unstructured":"Abu Hashim II, El-Dahan MS, Yusif RM, Abd-Elgawad AE, Arima H. Potential use of niosomal hydrogel as an ocular delivery system for atenolol. Biol Pharm Bull. 2014;37(4):541\u201351.","journal-title":"Biol Pharm Bull"},{"key":"1699_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopha.2017.06.043","volume":"93","author":"M Qumbar","year":"2017","unstructured":"Qumbar M, Ameeduzzafar ISS, Ali J, Ahmad J, Ali A. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. Biomed Pharmacother. 2017;93:255\u201366.","journal-title":"Biomed Pharmacother"},{"key":"1699_CR36","first-page":"7","volume":"492","author":"MA Lingan","year":"2011","unstructured":"Lingan MA, Sathali AAH, Kumar MV, Gokila A. Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Revs Chem Commun. 2011;492:7\u201317.","journal-title":"Sci Revs Chem Commun"},{"key":"1699_CR37","first-page":"731","volume":"3","author":"L Thomas","year":"2012","unstructured":"Thomas L, Viswanad V. Formulation and optimization of clotrimazole- loaded proniosomal gel using. Sci Pharm. 2012;3:731\u201348.","journal-title":"Sci Pharm"},{"key":"1699_CR38","first-page":"168","volume":"3","author":"CH Singh","year":"2011","unstructured":"Singh CH, Jain C, Kumar BN. Formulation, characterization, stability and invitro evaluation of nimesulide niosomes. Pharmacophore. 2011;3:168\u201385.","journal-title":"Pharmacophore."},{"key":"1699_CR39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10717544.2016.1247928","volume":"24","author":"GA Abdelbary","year":"2017","unstructured":"Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Del. 2017;24:309\u201319.","journal-title":"Drug Del"},{"key":"1699_CR40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2008.05.031","volume":"361","author":"M Mokhtar","year":"2008","unstructured":"Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104\u201311.","journal-title":"Int J Pharm"},{"issue":"10","key":"1699_CR41","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00417-010-1383-0","volume":"248","author":"IP Kaur","year":"2010","unstructured":"Kaur IP, Aggarwal D, Singh H, Kakkar S. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol. 2010;248(10):1467\u201372.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1699_CR42","doi-asserted-by":"crossref","first-page":"101279","DOI":"10.1016\/j.jddst.2019.101279","volume":"54","author":"E-BI Ameeduzzafar","year":"2019","unstructured":"Ameeduzzafar E-BI, Alruwaili NK, Elkomy MH, Ahmad J, Afzal M, Ahmad N, et al. Development of novel dapagliflozin loaded solid self-nanoemulsifying oral delivery system: physiochemical characterization and in vivo antidiabetic activity. J Drug Del Sci Tech. 2019;54:101279.","journal-title":"J Drug Del Sci Tech"},{"key":"1699_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics10040185","volume":"10","author":"LK Yeo","year":"2018","unstructured":"Yeo LK, Olusanya TOB, Chaw CS, Elkordy AA. Brief effect of a small hydrophobic drug (cinnarizine) on the physicochemical characterisation of niosomes produced by thin-film hydration and microfluidic methods. Pharmaceutics. 2018;10:185.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1699_CR44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejpb.2007.12.020","volume":"69","author":"FS Nielsen","year":"2008","unstructured":"Nielsen FS, Petersen KB, Mullertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm. 2008;69(2):553\u201362.","journal-title":"Eur J Pharm Biopharm"},{"key":"1699_CR45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajps.2015.02.001","volume":"10","author":"Y Zubairu","year":"2015","unstructured":"Zubairu Y, Negi LM, Iqbal Z, Talegaonkar S. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations. Asian J Pharm Sci. 2015;10:322\u201330.","journal-title":"Asian J Pharm Sci"},{"key":"1699_CR46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0014-4835(71)80061-1","volume":"11","author":"D Maurice","year":"1971","unstructured":"Maurice D. The tonicity of an eye drop and its dilution by tears. Exp Eye Res. 1971;11:30\u20133.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1699_CR47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nano.2008.07.003","volume":"5","author":"SM Agnihotri","year":"2009","unstructured":"Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine. 2009;5(1):90\u20135.","journal-title":"Nanomedicine."},{"issue":"3","key":"1699_CR48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0887-2333(94)90170-8","volume":"8","author":"MP Vinardell","year":"1994","unstructured":"Vinardell MP, Macian M. Comparative study of the HET-CAM test and the Draize eye test for assessment of irritancy potential. Toxicol in Vitro. 1994;8(3):467\u201370.","journal-title":"Toxicol in Vitro"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01699-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01699-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01699-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:13:41Z","timestamp":1622848421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01699-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1699"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01699-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"4 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"167"}}